The post One Of These Is Set For 3,000% Growth In 2025; Chainlink, VeChain, Remittix Or Ripple (XRP) appeared on BitcoinEthereumNews.com. Crypto investors are scanning the market for the next big breakout, with established names like Chainlink, VeChain, and Ripple (XRP) holding strong positions but showing mixed momentum.  Each has a narrative, from enterprise adoption to financial integration, yet the hunt for exponential gains is shifting toward projects that combine real-world use cases with fresh upside.  Among these contenders, many analysts argue that Remittix (RTX) may be the altcoin with the clearest path to 3,000% growth in 2025. Chainlink Holding Crucial Levels Chainlink trades near $24 after losing the $25 support. Despite the dip, analysts remain cautiously optimistic as LINK holds a rising channel with support around $23.5.  A partnership with Japan’s SBI Group reinforces its role in tokenized funds and real-world assets, boosting long-term credibility. However, analysts warn that LINK may retest the $20 area before targeting $95–$100, underscoring the volatility as it consolidates before a potential breakout. VeChain Keeps Steady Growth Path VeChain sits at $0.026, a price reflecting its enterprise-driven model rather than speculative hype. With major brands in luxury goods, pharmaceuticals, and agriculture adopting its solutions, VeChain continues building as a supply-chain-focused blockchain.  Forecasts suggest VET could edge toward $0.027–$0.03 by late 2025 if institutional adoption holds. While Vechain price predictions show growth is steady and credible, the trajectory is gradual compared to high-volatility competitors like Remittix. Ripple Building Institutional Dominance Ripple (XRP) trades around $3, holding its ground as one of the most adopted cryptos in global finance. With over 60 companies filing to create XRP reserves, its payment and settlement utility is strengthening. ETF filings from Wall Street giants like Grayscale and Bitwise add further legitimacy.  Analysts note that the creation of a potential national XRP reserve would supercharge adoption and $3.6 by September is highly realistic. Still, while XRP remains a heavyweight, upside projections… The post One Of These Is Set For 3,000% Growth In 2025; Chainlink, VeChain, Remittix Or Ripple (XRP) appeared on BitcoinEthereumNews.com. Crypto investors are scanning the market for the next big breakout, with established names like Chainlink, VeChain, and Ripple (XRP) holding strong positions but showing mixed momentum.  Each has a narrative, from enterprise adoption to financial integration, yet the hunt for exponential gains is shifting toward projects that combine real-world use cases with fresh upside.  Among these contenders, many analysts argue that Remittix (RTX) may be the altcoin with the clearest path to 3,000% growth in 2025. Chainlink Holding Crucial Levels Chainlink trades near $24 after losing the $25 support. Despite the dip, analysts remain cautiously optimistic as LINK holds a rising channel with support around $23.5.  A partnership with Japan’s SBI Group reinforces its role in tokenized funds and real-world assets, boosting long-term credibility. However, analysts warn that LINK may retest the $20 area before targeting $95–$100, underscoring the volatility as it consolidates before a potential breakout. VeChain Keeps Steady Growth Path VeChain sits at $0.026, a price reflecting its enterprise-driven model rather than speculative hype. With major brands in luxury goods, pharmaceuticals, and agriculture adopting its solutions, VeChain continues building as a supply-chain-focused blockchain.  Forecasts suggest VET could edge toward $0.027–$0.03 by late 2025 if institutional adoption holds. While Vechain price predictions show growth is steady and credible, the trajectory is gradual compared to high-volatility competitors like Remittix. Ripple Building Institutional Dominance Ripple (XRP) trades around $3, holding its ground as one of the most adopted cryptos in global finance. With over 60 companies filing to create XRP reserves, its payment and settlement utility is strengthening. ETF filings from Wall Street giants like Grayscale and Bitwise add further legitimacy.  Analysts note that the creation of a potential national XRP reserve would supercharge adoption and $3.6 by September is highly realistic. Still, while XRP remains a heavyweight, upside projections…

One Of These Is Set For 3,000% Growth In 2025; Chainlink, VeChain, Remittix Or Ripple (XRP)

3 min read

Crypto investors are scanning the market for the next big breakout, with established names like Chainlink, VeChain, and Ripple (XRP) holding strong positions but showing mixed momentum. 

Each has a narrative, from enterprise adoption to financial integration, yet the hunt for exponential gains is shifting toward projects that combine real-world use cases with fresh upside. 

Among these contenders, many analysts argue that Remittix (RTX) may be the altcoin with the clearest path to 3,000% growth in 2025.

Chainlink trades near $24 after losing the $25 support. Despite the dip, analysts remain cautiously optimistic as LINK holds a rising channel with support around $23.5. 

A partnership with Japan’s SBI Group reinforces its role in tokenized funds and real-world assets, boosting long-term credibility. However, analysts warn that LINK may retest the $20 area before targeting $95–$100, underscoring the volatility as it consolidates before a potential breakout.

VeChain Keeps Steady Growth Path

VeChain sits at $0.026, a price reflecting its enterprise-driven model rather than speculative hype. With major brands in luxury goods, pharmaceuticals, and agriculture adopting its solutions, VeChain continues building as a supply-chain-focused blockchain. 

Forecasts suggest VET could edge toward $0.027–$0.03 by late 2025 if institutional adoption holds. While Vechain price predictions show growth is steady and credible, the trajectory is gradual compared to high-volatility competitors like Remittix.

Ripple Building Institutional Dominance

Ripple (XRP) trades around $3, holding its ground as one of the most adopted cryptos in global finance. With over 60 companies filing to create XRP reserves, its payment and settlement utility is strengthening. ETF filings from Wall Street giants like Grayscale and Bitwise add further legitimacy. 

Analysts note that the creation of a potential national XRP reserve would supercharge adoption and $3.6 by September is highly realistic. Still, while XRP remains a heavyweight, upside projections remain modest relative to newer altcoins.

Why Remittix Is the Real 3,000% Candidate

Remittix positions itself as the standout contender for exponential growth. The PayFi project is solving the global remittance challenge with crypto-to-bank transfers across 30+ countries, transparent FX quotes, and merchant-ready Remittix Pay APIs. 

Currently priced at $0.0987, Remittix has already raised over $21.8 million and sold more than 625 million tokens. A second CEX reveal is due at the $22M milestone, and a wallet beta launching in Q3 2025 is driving much needed FOMO.

Key highlights investors track:

  • Direct crypto-to-bank transfers in 30+ countries
  • Support for 40+ cryptos and 30+ fiat currencies at launch
  • Transparent FX and flat fee structure
  • API integration for businesses and freelancers

While Chainlink and VeChain focus on utility and Ripple cements its financial integration, only Remittix pairs massive real-world demand with early-stage growth potential. With confirmed listings, upcoming milestones, and scalable utility, many analysts project 3,000% growth before 2026, positioning the low cap gem as the most exciting play among the four.

Discover the future of PayFi with Remittix by checking out their project here:

Website: https://remittix.io/  

Socials: https://linktr.ee/remittix

$250K Giveaway: https://gleam.io/competitions/nz84L-250000-remittix-giveaway

Source: https://www.cryptopolitan.com/one-of-these-is-set-for-3000-growth-in-2025-chainlink-vechain-remittix-or-ripple-xrp/

Market Opportunity
NEAR Logo
NEAR Price(NEAR)
$1.138
$1.138$1.138
-0.78%
USD
NEAR (NEAR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump swears he'll donate winnings in $10 billion lawsuit against his own IRS

Trump swears he'll donate winnings in $10 billion lawsuit against his own IRS

President Donald Trump told NBC News' Tom Llamas in an interview released on Wednesday that he has no interest in actually keeping any money he wins from his lawsuit
Share
Rawstory2026/02/05 10:43
US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike

US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike

The post US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike appeared on BitcoinEthereumNews.com. US President Donald Trump said that
Share
BitcoinEthereumNews2026/02/05 10:23
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11